Ductal Carcinoma in Situ Diagnosis

MarginProbe® Clean Margins Matter

Clinically stated, the objective is a clean, negative margin, with all six
surfaces of an excised tumor cancer-free. MarginProbe makes
possible lumpectomy margin assessment while in the operating room.

What if surgery got
cancer in the first try?

With MarginProbe, surgeons can assess the tissue in the operating room to give them confidence in their assessment of cancerous margins primary lumpectomy surgery.

Learn more

With MarginProbe, surgeons can identify positive margins in real-time on the lumpectomy specimen providing them information to enable them to decide if they should take additional tissue during the first lumpectomy surgery.

The technology uses radio-frequency (RF) electrical fields to probe the tissue in order to identify any cancer that may be remaining on the surface of the tissue removed from the breast. If MarginProbe identifies cancer on the surface of the tissue the surgeon decides if they will remove additional tissue from the breast at the time of surgery.

Margins Matter

The question “Did we get all the cancer?” weighs on every surgeon and patient’s mind for days after surgery until they receive the final pathology report. The goal of every lumpectomy is to get clean or clear margins. This means to remove the cancerous tissue with a small rim of normal tissues surrounding it, called the margin. With MarginProbe, surgeons have greater confidence that they can get clean margins in the first lumpectomy procedure. Watch the videos to learn more about how surgeons get clean margins in the operating room.

Is MarginProbe® right for me?

Depending on your cancer diagnosis, your doctor will recommend a lumpectomy or a mastectomy to treat your cancer. If your cancer is being treated with a lumpectomy then MarginProbe can give you greater confidence that your surgeon will have more information to determine if all the cancer is removed in your first surgery. Watch the videos to learn more about how patients benefit from MarginProbe.

Learn more
Choosing between a lumpectomy and mastectomy
Dr. Stephanie Akbari, MD
Breast Oncologist, Director of Applied Surgical Technology – Inova Health Systems
Which patients are suited for MarginProbe?
Dr. Stephanie Akbari, MD
Breast Oncologist, Director of Applied Surgical Technology – Inova Health Systems
How does MarginProbe help with a lumpectomy?
Dr. Alice Police, MD
Breast Cancer Surgical Oncologist – UC Irvine Medical Center
Breast Cancer Surgical Oncologist – UC Irvine Medical Center
Dr. Stephanie Akbari, MD
Breast Oncologist, Director of Applied Surgical Technology – Inova Health Systems

Treating DCIS

Ductal Carcinoma in Situ (DCIS) can be a challenge for a surgeon to identify during surgery because it doesn’t form a lump so the surgeon can’t feel or see it. MarginProbe has been proven to be equally as effective in identifying DCIS as it is in identifying invasive cancers. Watch the videos to learn more about DCIS and how surgeons overcome the challenges with DCIS during surgery.

Learn more
What is DCIS?
Dr. Michele Carpenter, MD
Breast Surgeon, Medical Director St. Joseph’s Hospital
How do you get clean margins with DCIS?
Dr. Stephanie Akbari, MD
Breast Oncologist, Director of Applied Surgical Technology – Inova Health Systems
Is it harder to have clean margins with DCIS?
Dr. Michele Carpenter, MD
Breast Surgeon, Medical Director – St. Joseph’s Hospital
Why is DCIS more challenging than invasive cancer?
Dr. Christina Casteel, MD
General Surgeon – Sharp Hospital, San Diego

Patient Stories

MarginProbe Resources

Instructions for Use
How can we help?

Before you commit to a particular
course of treatment, talk to us.